PRESS RELEASES

PRESS RELEASES

November 7, 2016
*See footnote about the use of pro forma financial information Third Quarter 2016 Highlights: Company revenue increased 10.5% to $23.1 million , as compared to pro forma revenue of $20.9 million in third quarter 2015 Gross profit increased to $16.0 million , as compared to pro forma third quarter
November 1, 2016
BELGRADE, Mont. , Nov. 01, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today announced that the NYSE MKT LLC (the "Exchange") notified the Company that
October 11, 2016
*See footnote about the use of pro forma financial information Record Third Quarter 2016 Revenue in the range of $23.0 million to $23.3 million Third Quarter 2016 Revenue represents an increase of 10.0% to 11.5% compared to pro forma Third Quarter 2015 Revenue of $20.9 million and a sequential
August 19, 2016
BELGRADE, Mont. , Aug. 19, 2016 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE MKT:XTNT), a leader in the development, manufacturing and marketing of orthopedic products for domestic and international markets, today announced that the NYSE MKT LLC (the "Exchange") notified the Company that